Gall Matthew bought TNGX
May 1, 2026 · Form 4 insider transaction
Gall Matthew bought 240,000 shares of Tango Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
240,000
Price
$0.00
Total value
N/A
InsiderGall Matthew
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMay 1, 2026
Filing dateMay 5, 2026
Shares owned after240,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option shall vest and become exercisable over a four-year period, at a rate of 25% on April 15, 2027 with the remaining option shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.